TY - JOUR
T1 - Prognostic outcomes of immediate complete lymph node dissection versus observation in patients with acral melanoma of the sole with sentinel node metastasis
T2 - a retrospective, multicenter study
AU - Inoue, Sadao
AU - Koizumi, Shigeru
AU - Yamazaki, Naoya
AU - Ichigozaki, Yuki
AU - Kitagawa, Hiroshi
AU - Kiniwa, Yukiko
AU - Sato, Sayuri
AU - Takai, Toshihiro
AU - Doi, Reiichi
AU - Ito, Takamichi
AU - Yasuda, Masahito
AU - Kuwatsuka, Yutaka
AU - Maekawa, Takeo
AU - Asai, Jun
AU - Miyagawa, Takuya
AU - Matsushita, Shigeto
AU - Funakoshi, Takeru
AU - Yamamoto, Yosuke
AU - Inozume, Takashi
AU - Kishi, Akiko
AU - Takenouchi, Tatsuya
AU - Kokubu, Hiraku
AU - Ito, Shusaku
AU - Umeda, Yoshiyasu
AU - Yamamoto, Yuki
AU - Ishizuki, Shoichiro
AU - Iino, Shiro
AU - Uchi, Hiroshi
AU - Nakagawa, Tomoe
AU - Inafuku, Kazuhiro
AU - Haga, Takahiro
AU - Kaneko, Takahide
AU - Nakagawa, Masahiro
AU - Kamiya, Hideki
AU - Arima, Masaru
AU - Hoashi, Toshihiko
AU - Hiura, Azusa
AU - Kanazawa, Nobuo
AU - Manabe, Keiko
AU - Ishikawa, Masashi
AU - Asagoe, Kenji
AU - Iwasawa, Utsugi
AU - Kadono, Takafumi
AU - Hatta, Naohito
AU - Minami, Shoichiro
AU - Nakano, Eiji
AU - Ogata, Dai
AU - Fukushima, Satoshi
AU - Uhara, Hisashi
AU - Nakama, Kenta
AU - Komori, Takaya
AU - Igawa, Ken
AU - Nakamura, Yasuhiro
N1 - Publisher Copyright:
© The Author(s) under exclusive licence to Japan Society of Clinical Oncology 2025.
PY - 2026/1
Y1 - 2026/1
N2 - Background: The clinical utility of immediate complete lymph node dissection (CLND) following positive sentinel node (SN) remains controversial in acral melanoma (AM), in Asian populations where AM is more prevalent. This study aimed to compare the survival outcomes of immediate CLND versus observation (OBS) in Japanese patients with stage III sole AM and positive SN. Methods: This retrospective, multicenter study included 154 patients (CLND: 90, OBS: 64) with stage III sole AM with positive SN, across 44 Japanese institutions. Recurrence-free survival (RFS), distant metastasis-free survival (DMFS), regional metastasis-free survival (RMFS), and overall survival (OS) were compared between the two groups. Cox multivariable analysis and propensity score matching (PSM) were performed to adjust for potential confounders. Results: With a median follow-up of 3.9 years, non-significant differences were observed in RFS, DMFS, RMFS, or OS between the CLND and OBS groups (P = 0.33, 0.32, 0.08, and 0.21, respectively). Cox multivariable analysis identified N3a nodal stage as an independent negative factor for OS (HR: 2.6, P = 0.02), whereas CLND and other variables were not associated. After PSM, 92 (46 each) were matched. RFS and DMFS remained comparable (P = 0.16 and 0.19), with a non-significant trend toward improved RMFS in the CLND group (P = 0.08), and no difference in OS (P = 0.14). Conclusions: Immediate CLND did not provide a survival advantage over OBS in patients with stage III sole AM and positive SN. These findings do not support the routine use of CLND in this population. Trial registration Not applicable.
AB - Background: The clinical utility of immediate complete lymph node dissection (CLND) following positive sentinel node (SN) remains controversial in acral melanoma (AM), in Asian populations where AM is more prevalent. This study aimed to compare the survival outcomes of immediate CLND versus observation (OBS) in Japanese patients with stage III sole AM and positive SN. Methods: This retrospective, multicenter study included 154 patients (CLND: 90, OBS: 64) with stage III sole AM with positive SN, across 44 Japanese institutions. Recurrence-free survival (RFS), distant metastasis-free survival (DMFS), regional metastasis-free survival (RMFS), and overall survival (OS) were compared between the two groups. Cox multivariable analysis and propensity score matching (PSM) were performed to adjust for potential confounders. Results: With a median follow-up of 3.9 years, non-significant differences were observed in RFS, DMFS, RMFS, or OS between the CLND and OBS groups (P = 0.33, 0.32, 0.08, and 0.21, respectively). Cox multivariable analysis identified N3a nodal stage as an independent negative factor for OS (HR: 2.6, P = 0.02), whereas CLND and other variables were not associated. After PSM, 92 (46 each) were matched. RFS and DMFS remained comparable (P = 0.16 and 0.19), with a non-significant trend toward improved RMFS in the CLND group (P = 0.08), and no difference in OS (P = 0.14). Conclusions: Immediate CLND did not provide a survival advantage over OBS in patients with stage III sole AM and positive SN. These findings do not support the routine use of CLND in this population. Trial registration Not applicable.
KW - Acral melanoma
KW - Adjuvant therapy
KW - Immediate complete lymph node dissection
KW - Micrometastasis
KW - Observation
KW - Sentinel lymph node biopsy
UR - https://www.scopus.com/pages/publications/105024005454
UR - https://www.scopus.com/pages/publications/105024005454#tab=citedBy
U2 - 10.1007/s10147-025-02936-6
DO - 10.1007/s10147-025-02936-6
M3 - Article
C2 - 41345808
AN - SCOPUS:105024005454
SN - 1341-9625
VL - 31
SP - 214
EP - 222
JO - International Journal of Clinical Oncology
JF - International Journal of Clinical Oncology
IS - 1
ER -